797 related articles for article (PubMed ID: 29021396)
21. Thiostrepton Reactivates Latent HIV-1 through the p-TEFb and NF-κB Pathways Mediated by Heat Shock Response.
Peng W; Hong Z; Chen X; Gao H; Dai Z; Zhao J; Liu W; Li D; Deng K
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094131
[TBL] [Abstract][Full Text] [Related]
22. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.
Mousseau G; Kessing CF; Fromentin R; Trautmann L; Chomont N; Valente ST
mBio; 2015 Jul; 6(4):e00465. PubMed ID: 26152583
[TBL] [Abstract][Full Text] [Related]
23. Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients.
Spivak AM; Bosque A; Balch AH; Smyth D; Martins L; Planelles V
Antimicrob Agents Chemother; 2015 Oct; 59(10):5984-91. PubMed ID: 26169416
[TBL] [Abstract][Full Text] [Related]
24. HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells.
Chan CN; Trinité B; Lee CS; Mahajan S; Anand A; Wodarz D; Sabbaj S; Bansal A; Goepfert PA; Levy DN
Retrovirology; 2016 Jan; 13():1. PubMed ID: 26728316
[TBL] [Abstract][Full Text] [Related]
25. Bryostatin-1 Decreases HIV-1 Infection and Viral Production in Human Primary Macrophages.
Hany L; Turmel MO; Barat C; Ouellet M; Tremblay MJ
J Virol; 2022 Feb; 96(4):e0195321. PubMed ID: 34878918
[TBL] [Abstract][Full Text] [Related]
26. An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients.
Spina CA; Anderson J; Archin NM; Bosque A; Chan J; Famiglietti M; Greene WC; Kashuba A; Lewin SR; Margolis DM; Mau M; Ruelas D; Saleh S; Shirakawa K; Siliciano RF; Singhania A; Soto PC; Terry VH; Verdin E; Woelk C; Wooden S; Xing S; Planelles V
PLoS Pathog; 2013; 9(12):e1003834. PubMed ID: 24385908
[TBL] [Abstract][Full Text] [Related]
27. Identification of Combinations of Protein Kinase C Activators and Histone Deacetylase Inhibitors That Potently Reactivate Latent HIV.
Curreli F; Ahmed S; Victor SMB; Debnath AK
Viruses; 2020 Jun; 12(6):. PubMed ID: 32503121
[TBL] [Abstract][Full Text] [Related]
28. Bryostatin-1 synergizes with histone deacetylase inhibitors to reactivate HIV-1 from latency.
Pérez M; de Vinuesa AG; Sanchez-Duffhues G; Marquez N; Bellido ML; Muñoz-Fernandez MA; Moreno S; Castor TP; Calzado MA; Muñoz E
Curr HIV Res; 2010 Sep; 8(6):418-29. PubMed ID: 20636281
[TBL] [Abstract][Full Text] [Related]
29. Dual effect of the broad spectrum kinase inhibitor midostaurin in acute and latent HIV-1 infection.
Garcia-Vidal E; Badia R; Pujantell M; Castellví M; Felip E; Clotet B; Riveira-Muñoz E; Ballana E; Esté JA
Antiviral Res; 2019 Aug; 168():18-27. PubMed ID: 31077767
[TBL] [Abstract][Full Text] [Related]
30. Development of a Novel
Wong ME; Johnson CJ; Hearps AC; Jaworowski A
J Virol; 2021 Sep; 95(19):e0022721. PubMed ID: 34287050
[TBL] [Abstract][Full Text] [Related]
31. Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation.
Yang HC; Xing S; Shan L; O'Connell K; Dinoso J; Shen A; Zhou Y; Shrum CK; Han Y; Liu JO; Zhang H; Margolick JB; Siliciano RF
J Clin Invest; 2009 Nov; 119(11):3473-86. PubMed ID: 19805909
[TBL] [Abstract][Full Text] [Related]
32. The Effect of JAK1/2 Inhibitors on HIV Reservoir Using Primary Lymphoid Cell Model of HIV Latency.
de Armas LR; Gavegnano C; Pallikkuth S; Rinaldi S; Pan L; Battivelli E; Verdin E; Younis RT; Pahwa R; Williams SL; Schinazi RF; Pahwa S
Front Immunol; 2021; 12():720697. PubMed ID: 34531866
[TBL] [Abstract][Full Text] [Related]
33. Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal.
Stoszko M; De Crignis E; Rokx C; Khalid MM; Lungu C; Palstra RJ; Kan TW; Boucher C; Verbon A; Dykhuizen EC; Mahmoudi T
EBioMedicine; 2016 Jan; 3():108-121. PubMed ID: 26870822
[TBL] [Abstract][Full Text] [Related]
34. Cellular Gene Modulation of HIV-Infected CD4 T Cells in Response to Serial Treatment with the Histone Deacetylase Inhibitor Vorinostat.
Maxwell JW; Falcinelli SD; Nefedov A; Dorfmeier C; Wu G; Dewey M; Webber AL; Archin NM; Margolis DM; Hazuda DJ; Barnard RJO; Howell BJ
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295913
[TBL] [Abstract][Full Text] [Related]
35. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H
J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056
[TBL] [Abstract][Full Text] [Related]
36. Pharmacologic reactivation of latent feline immunodeficiency virus ex vivo in peripheral CD4+ T-lymphocytes.
McDonnel SJ; Sparger EE; Luciw PA; Murphy BG
Virus Res; 2012 Dec; 170(1-2):174-9. PubMed ID: 23073179
[TBL] [Abstract][Full Text] [Related]
37. Inhibitors of histone deacetylases: correlation between isoform specificity and reactivation of HIV type 1 (HIV-1) from latently infected cells.
Huber K; Doyon G; Plaks J; Fyne E; Mellors JW; Sluis-Cremer N
J Biol Chem; 2011 Jun; 286(25):22211-8. PubMed ID: 21531716
[TBL] [Abstract][Full Text] [Related]
38. HIV Provirus Stably Reproduces Parental Latent and Induced Transcription Phenotypes Regardless of the Chromosomal Integration Site.
Hashemi FB; Barreto K; Bernhard W; Hashemi P; Lomness A; Sadowski I
J Virol; 2016 Jun; 90(11):5302-14. PubMed ID: 26984732
[TBL] [Abstract][Full Text] [Related]
39. Chidamide, a histone deacetylase inhibitor-based anticancer drug, effectively reactivates latent HIV-1 provirus.
Yang W; Sun Z; Hua C; Wang Q; Xu W; Deng Q; Pan Y; Lu L; Jiang S
Microbes Infect; 2018; 20(9-10):626-634. PubMed ID: 29126877
[TBL] [Abstract][Full Text] [Related]
40. Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents.
Marsden MD; Wu X; Navab SM; Loy BA; Schrier AJ; DeChristopher BA; Shimizu AJ; Hardman CT; Ho S; Ramirez CM; Wender PA; Zack JA
Virology; 2018 Jul; 520():83-93. PubMed ID: 29800728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
